We express our heartfelt gratitude to our clients and partners for a remarkable 2023. We eagerly anticipate an amazing 2024. Our best wishes for a prosperous and healthy New Year.

Another brilliant application of multiplex proteomics! This study presents a novel method to assess aging in individual organs. Unlike general aging scores that offer limited intervention strategies, organ-scores is a practical idea for improving health eu1.hubs.ly/H06YPWc0

We are proud of the visit of our Prime Minister Kyriakos Mitsotakis to Protavio to showcase innovation made in Greece! Protavio has developed the world's best pipeline for the discovery to manufacturing of proteomic multiplex diagnostics. Better diagnostics 4 better health!

Our new secret-itn publication is now available at iScience journal demonstrating the role of PKD in secreting invasion mediators in TNBC. Thank you Leonidas Alexopoulos and colleagues at Protavio Ltd, Angelika Hausser and Dr. Connie Jimenez for the collaboration! cell.com/iscience/fullt… 📷

After one year of hard work, we are excited to launch the powerful #Olink Explore services to measure 1000s of proteins in a few ul of sample. Together w/ #Luminex #xMAP technology, we have built the most powerful biomarker discovery engine: 5-10x faster & 3-100x broader!

Μultiplex proteomics for multi-cancer detection! “proteome-based screening test showed promising performance compared with other technologies & could be a starting point for developing a new generation of screening tests for the early detection of cancer” eu1.hubs.ly/H07pZX_0

Have you followed us Protavio Ltd on X? Embark on our amazing journeys from proteomic discovery to clinical use, and help us continue relying on reputation and word of mouth! Stay tuned for amazing offers in our proteomic services shortly! ...Starting this Monday!

Proteomics sample testing contest! Protavio is celebrating its new multi-platform proteomic facility and offers a free #Olink® Explore 384 Inflammation Panel for 20 samples. Like/share and complete this online form to take part in this contest: eu1.hubs.ly/H07zv9P0

Are you attending Biomarkers UK in London from February 29th to March 1st? We invite you to visit us at booth 49 and meet our team to discuss your biomarker projects.

We are thrilled to announce the integration of the Olink Explore platform into our service offerings! This marks a significant milestone in our mission to harness the power of proteomics for better health. Learn more by reading our latest blog post. eu1.hubs.ly/H07LxSL0

Lung cancer is the leading cause of cancer death globally. The Global Cancer Observatory from IARC recently released new estimates: in Europe the cumulative risk for cancer incidence is 65% and for cancer mortality is almost half (28,5%). Lung cancer has the highest mortality.

🎉Protavio Announces the Winner of the Proteomics Sample Testing Contest!🎉 We are excited to announce Maria Grigoriou, a Postdoc Fellow at the Biomedical Research Foundation Academy of Athens under the supervision of Prof. Boumpas as the winner of our contest! Read more on our news post eu1.hubs.ly/H08dfQw0

Protavio is at the forefront of colorectal cancer (CRC) screening through participation in the DIOPTRA Project aiming to discover a blood-based protein biomarker panel and develop a multiplex screening kit for early cancer and advanced adenoma detection. eu1.hubs.ly/H08h-Jh0

Our GMP-produced 13-plex Pneumococcal IgG Serological Luminex Assay is ready for shipment! It measures IgG antibodies against 13 strains of Streptococcus pneumonia found in the Prevenar 13. Do you like our kit design? Learn more eu1.hubs.ly/H08kKWF0 #pneumoniae #pcv13

We are hiring! There are two new opportunities to work with us! The first opportunity is on Project Management and the other is open to anyone who possesses a **unique talent** that aligns with our vision. Click below and select any of the two positions. eu1.hubs.ly/H08mfWt0

We're excited to announce the latest addition to the Protavio family of xMAP instruments: the Luminex xMAP INTELLIFLEX DR-SE System. Stay tuned as we harness its potential for custom multiplex assays, advancing biomarker profiling and clinical impact. eu1.hubs.ly/H08pVH90

Protavio Ltd is seeking a driven and experienced Project Manager to join our team linkedin.com/jobs/view/3886…

Ο συνεργάτης μας, Καθηγητής Ιωάννης Παπανικολάου εμφανίστηκε στην εκπομή του OPEN και συζήτησε την από κοινού ανάπτυξη ενός νέου τεστ διάγνωσης καρκίνου του παχέος εντέρου μέσω της κοινοπραξίας του DIOPTRA Project eu1.hubs.ly/H08wsXc0

Protavio will be attending the upcoming Olink Proteomics World virtual conference on Thursday September 26th. Come check out our work at the digital poster hall and discuss on its application for biomarker discovery in early cancer detection! eu1.hubs.ly/H0cBSMB0

Protavio presented at the 8th Network Meeting for Luminex Immune Assay Users. Our co-founder, Dr. Leonidas Alexopoulos, shared how Protavio implemented a GMP & ISO13485 system: a crucial component for translating multiplex biomarkers to clinical practice. eu1.hubs.ly/H0cHWKx0